Erythropoietin Augments Survival of Glioma Cells After Radiation and Temozolomide-Reference-Cited by-同舟云学术

Erythropoietin Augments Survival of Glioma Cells After Radiation and Temozolomide

Published:2008-11 Issue:3 Volume:72 Page:927-934
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Hassouna Imam,Sperling Swetlana,Kim Ella,Schulz-Schaeffer Walter,Rave-Fränk Margret,Hasselblatt Martin,Jelkmann Wolfgang,Giese Alf,Ehrenreich Hannelore

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference45 articles.

1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

2. Managing the cognitive effects of brain tumor radiation therapy;Butler;Curr Treat Options Oncol,2006

3. Cognitive sequelae of brain tumor treatment;Byrne;Curr Opin Neurol,2005

4. Erythropoietin after a century of research: Younger than ever;Jelkmann;Eur J Haematol,2007

5. In vivo evidence that erythropoietin protects neurons from ischemic damage;Sakanaka;Proc Natl Acad Sci U S A,1998

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Centrosymmetric homo- and heteroleptic core paddle-wheel copper(II) carboxylates; Syntheses, crystal structures, antioxidant, anticancer and enzyme inhibition activity;Journal of Molecular Structure;2024-10

2. Synthesis, characterization, antioxidant, antileishmanial, anticancer, DNA and theoretical SARS-CoV-2 interaction studies of copper(II) carboxylate complexes;Journal of Molecular Structure;2022-04

3. HIF-опосредованные механизмы взаимосвязи устойчивости к гипоксии и опухолевого роста;Биохимия;2021-10-01

4. HIF-Dependent Mechanisms of Relationship between Hypoxia Tolerance and Tumor Development;Biochemistry (Moscow);2021-09-03

5. Hypoxia-Induced Cancer Cell Responses Driving Radioresistance of Hypoxic Tumors: Approaches to Targeting and Radiosensitizing;Cancers;2021-03-04